Apogee Therapeutics, Inc. (APGE)
NASDAQ:APGE
US Market
Holding APGE?
Track your performance easily

Apogee Therapeutics, Inc. (APGE) Income Statement

110 Followers

Apogee Therapeutics, Inc. Income Statement

Last quarter (Q2 2024), Apogee Therapeutics, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Apogee Therapeutics, Inc.'s net income was $-33.82M. See Apogee Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22
Total Revenue
---
Cost of Revenue
---
Gross Profit
---
Operating Expense
$ 125.49M$ 93.00M$ 30.73M
Operating Income
$ -125.49M$ -93.00M$ -30.73M
Net Non Operating Interest Income Expense
$ 19.86M$ 9.02M$ -9.06M
Other Income Expense
---
Pretax Income
$ -105.64M$ -83.98M$ -39.78M
Tax Provision
---
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -105.64M$ -83.98M$ -39.78M
Basic EPS
$ -5.53$ -3.36$ -16.16
Diluted EPS
$ -5.53$ -3.36$ -16.16
Basic Average Shares
$ 152.94M$ 25.01M$ 2.46M
Diluted Average Shares
$ 152.94M$ 25.01M$ 2.46M
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 125.49M$ 93.00M$ 30.73M
Net Income From Continuing And Discontinued Operation
$ -105.64M$ -83.98M$ -39.78M
Normalized Income
$ -49.94M--
Interest Expense
---
EBIT
$ -103.14M$ -83.98M-
EBITDA
$ -103.08M$ -83.98M-
Currency in USD

Apogee Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis